Trial intelligence / Profile preview

Ketamine submucosal versus intravenous conscious sedation for pediatric wound repair

IRCT20171211037834N2Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Sep 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of ketamine in traumatic wound (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Depth of sedation. Started Sep 2019; status: completed.

02

Drugs

ketamine
03

Conditions

traumatic wound

Beyond the preview

Go deeper on IRCT20171211037834N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171211037834N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call